US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist

4.330
+0.010+0.23%

Close Nov 21 16:00 ET

37.45MMarket Cap-1011P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

35.98%-5.01M

4.56%-6.38M

-40.20%-12.89M

-16.80%-31.1M

-26.90%-7.39M

-41.69%-7.82M

7.73%-6.69M

-14.49%-9.2M

10.20%-26.62M

-0.26%-5.83M

Net income from continuing operations

10.04%-7.47M

15.45%-7.55M

-42.13%-10.44M

-9.57%-34.03M

-14.67%-9.46M

-14.47%-8.3M

-13.86%-8.93M

4.84%-7.35M

-2.08%-31.06M

-46.20%-8.25M

Depreciation and amortization

-112.50%-1K

-77.78%2K

-10.20%44K

-48.57%18K

100.00%8K

550.00%9K

-25.00%9K

-77.42%49K

34.62%35K

Other non cash items

--0

99.26%-1K

-1,407.69%-392K

---30K

---91K

---135K

---136K

---26K

----

Change In working capital

51,975.00%2.08M

-54.51%782K

-31.34%-3.03M

-53.96%965K

-14.96%1.55M

-99.65%4K

6,511.54%1.72M

-159.55%-2.31M

190.58%2.1M

364.49%1.83M

-Change in receivables

-109.84%-6K

140.63%13K

31.82%29K

114.13%13K

13.64%-38K

481.25%61K

-28.00%-32K

414.29%22K

-167.65%-92K

-266.67%-44K

-Change in prepaid assets

7.81%345K

53.85%260K

32.04%-437K

38.01%679K

42.39%833K

-32.20%320K

-61.33%169K

35.83%-643K

145.30%492K

135.89%585K

-Change in payables and accrued expense

562.60%1.74M

-67.83%509K

-55.48%-2.63M

-83.90%273K

-41.04%757K

-155.52%-377K

509.84%1.58M

-1,519.33%-1.69M

224.34%1.7M

238.66%1.28M

Cash from discontinued investing activities

Operating cash flow

35.98%-5.01M

4.56%-6.38M

-40.20%-12.89M

-16.80%-31.1M

-26.90%-7.39M

-41.69%-7.82M

7.73%-6.69M

-14.49%-9.2M

10.20%-26.62M

-0.26%-5.83M

Investing cash flow

Cash flow from continuing investing activities

140.60%1M

194.58%10.74M

154.34%6.17M

5.95M

1.08M

-2.46M

-143.74%-11.36M

-37,760.00%-11.36M

Net PPE purchase and sale

----

--0

----

30.00%-21K

----

Net investment purchase and sale

--0

140.60%1M

194.75%10.74M

154.44%6.17M

--5.95M

--1.08M

---2.46M

---11.34M

Cash from discontinued investing activities

Investing cash flow

--0

140.60%1M

194.58%10.74M

154.34%6.17M

--5.95M

--1.08M

---2.46M

-143.74%-11.36M

-37,760.00%-11.36M

Financing cash flow

Cash flow from continuing financing activities

496.78%1.73M

98.38%-5K

29.84%-576K

256.21%742K

-33.44%-435K

-28,600.00%-574K

-1,616.67%-309K

-327.60%-821K

-475K

Net common stock issuance

506.10%1.73M

--0

13.33%-585K

251.67%725K

-116.24%-426K

---579K

---305K

---675K

---478K

Proceeds from stock option exercised by employees

--0

----

-60.67%35K

-29.17%17K

--0

----

27.14%89K

--24K

Net other financing activities

55.56%-4K

15.38%-11K

-25.00%-5K

88.94%-26K

--0

94.51%-9K

59.38%-13K

77.78%-4K

10.31%-235K

---21K

Cash from discontinued financing activities

Financing cash flow

496.78%1.73M

--0

98.38%-5K

29.84%-576K

256.21%742K

-33.44%-435K

-28,600.00%-574K

-1,616.67%-309K

-327.60%-821K

---475K

Net cash flow

Beginning cash position

-55.63%16.8M

-47.37%23.18M

-37.37%35.08M

-40.93%56.01M

-51.73%35.56M

-52.38%37.86M

-49.24%44.04M

-40.93%56.01M

-3.92%94.81M

-26.81%73.67M

Current changes in cash

-42.30%-3.28M

-3.30%-6.38M

0.58%-11.9M

46.06%-20.93M

97.29%-479K

60.56%-2.31M

14.78%-6.18M

-48.66%-11.97M

-902.64%-38.8M

-202.33%-17.66M

End cash Position

-61.98%13.52M

-55.63%16.8M

-47.37%23.18M

-37.37%35.08M

-51.73%35.56M

-52.38%37.86M

-49.24%44.04M

-40.93%56.01M

Free cash flow

35.98%-5.01M

4.56%-6.38M

-40.20%-12.89M

-16.71%-31.1M

-26.44%-7.39M

-41.69%-7.82M

7.73%-6.69M

-14.49%-9.2M

10.22%-26.64M

-0.10%-5.85M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	35.98%-5.01M	4.56%-6.38M	-40.20%-12.89M	-16.80%-31.1M	-26.90%-7.39M	-41.69%-7.82M	7.73%-6.69M	-14.49%-9.2M	10.20%-26.62M	-0.26%-5.83M
Net income from continuing operations	10.04%-7.47M	15.45%-7.55M	-42.13%-10.44M	-9.57%-34.03M	-14.67%-9.46M	-14.47%-8.3M	-13.86%-8.93M	4.84%-7.35M	-2.08%-31.06M	-46.20%-8.25M
Depreciation and amortization	-112.50%-1K	-77.78%2K	-77.78%2K	-10.20%44K	-48.57%18K	100.00%8K	550.00%9K	-25.00%9K	-77.42%49K	34.62%35K
Other non cash items	--0	--0	99.26%-1K	-1,407.69%-392K	---30K	---91K	---135K	---136K	---26K	----
Change In working capital	51,975.00%2.08M	-54.51%782K	-31.34%-3.03M	-53.96%965K	-14.96%1.55M	-99.65%4K	6,511.54%1.72M	-159.55%-2.31M	190.58%2.1M	364.49%1.83M
-Change in receivables	-109.84%-6K	140.63%13K	31.82%29K	114.13%13K	13.64%-38K	481.25%61K	-28.00%-32K	414.29%22K	-167.65%-92K	-266.67%-44K
-Change in prepaid assets	7.81%345K	53.85%260K	32.04%-437K	38.01%679K	42.39%833K	-32.20%320K	-61.33%169K	35.83%-643K	145.30%492K	135.89%585K
-Change in payables and accrued expense	562.60%1.74M	-67.83%509K	-55.48%-2.63M	-83.90%273K	-41.04%757K	-155.52%-377K	509.84%1.58M	-1,519.33%-1.69M	224.34%1.7M	238.66%1.28M
Cash from discontinued investing activities
Operating cash flow	35.98%-5.01M	4.56%-6.38M	-40.20%-12.89M	-16.80%-31.1M	-26.90%-7.39M	-41.69%-7.82M	7.73%-6.69M	-14.49%-9.2M	10.20%-26.62M	-0.26%-5.83M
Investing cash flow
Cash flow from continuing investing activities	0	0	140.60%1M	194.58%10.74M	154.34%6.17M	5.95M	1.08M	-2.46M	-143.74%-11.36M	-37,760.00%-11.36M
Net PPE purchase and sale	----	----	----	--0	----	----	----	----	30.00%-21K	----
Net investment purchase and sale	--0	--0	140.60%1M	194.75%10.74M	154.44%6.17M	--5.95M	--1.08M	---2.46M	---11.34M	---11.34M
Cash from discontinued investing activities
Investing cash flow	--0	--0	140.60%1M	194.58%10.74M	154.34%6.17M	--5.95M	--1.08M	---2.46M	-143.74%-11.36M	-37,760.00%-11.36M
Financing cash flow
Cash flow from continuing financing activities	496.78%1.73M	0	98.38%-5K	29.84%-576K	256.21%742K	-33.44%-435K	-28,600.00%-574K	-1,616.67%-309K	-327.60%-821K	-475K
Net common stock issuance	506.10%1.73M	--0	--0	13.33%-585K	251.67%725K	-116.24%-426K	---579K	---305K	---675K	---478K
Proceeds from stock option exercised by employees	--0	----	----	-60.67%35K	-29.17%17K	--0	----	----	27.14%89K	--24K
Net other financing activities	55.56%-4K	15.38%-11K	-25.00%-5K	88.94%-26K	--0	94.51%-9K	59.38%-13K	77.78%-4K	10.31%-235K	---21K
Cash from discontinued financing activities
Financing cash flow	496.78%1.73M	--0	98.38%-5K	29.84%-576K	256.21%742K	-33.44%-435K	-28,600.00%-574K	-1,616.67%-309K	-327.60%-821K	---475K
Net cash flow
Beginning cash position	-55.63%16.8M	-47.37%23.18M	-37.37%35.08M	-40.93%56.01M	-51.73%35.56M	-52.38%37.86M	-49.24%44.04M	-40.93%56.01M	-3.92%94.81M	-26.81%73.67M
Current changes in cash	-42.30%-3.28M	-3.30%-6.38M	0.58%-11.9M	46.06%-20.93M	97.29%-479K	60.56%-2.31M	14.78%-6.18M	-48.66%-11.97M	-902.64%-38.8M	-202.33%-17.66M
End cash Position	-61.98%13.52M	-55.63%16.8M	-47.37%23.18M	-37.37%35.08M	-37.37%35.08M	-51.73%35.56M	-52.38%37.86M	-49.24%44.04M	-40.93%56.01M	-40.93%56.01M
Free cash flow	35.98%-5.01M	4.56%-6.38M	-40.20%-12.89M	-16.71%-31.1M	-26.44%-7.39M	-41.69%-7.82M	7.73%-6.69M	-14.49%-9.2M	10.22%-26.64M	-0.10%-5.85M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data